Publication Information

{'id': 'https://openalex.org/W2752189410', 'doi': 'https://doi.org/10.21037/15559', 'title': 'The importance of RET -directed therapy in patients with RET- rearranged non-small cell lung cancer', 'display_name': 'The importance of RET -directed therapy in patients with RET- rearranged non-small cell lung cancer', 'publication_year': 2017, 'publication_date': '2017-07-09', 'ids': {'openalex': 'https://openalex.org/W2752189410', 'doi': 'https://doi.org/10.21037/15559', 'mag': '2752189410'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://tcr.amegroups.com/article/view/15559/html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764965054', 'display_name': 'Translational Cancer Research', 'issn_l': '2218-676X', 'issn': ['2218-676X', '2219-6803'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310321814', 'host_organization_name': 'AME Publishing Company', 'host_organization_lineage': ['https://openalex.org/P4310321814'], 'host_organization_lineage_names': ['AME Publishing Company'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5052865562', 'display_name': 'Kiyotaka Yoh', 'orcid': 'https://orcid.org/0000-0001-6928-357X'}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Kiyotaka Yoh', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5052865562'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 64}, 'biblio': {'volume': '6', 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10417', 'display_name': 'Advancements in Lung Cancer Research', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10417', 'display_name': 'Advancements in Lung Cancer Research', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11482', 'display_name': 'RNA Methylation and Modification in Gene Expression', 'score': 0.9938, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12334', 'display_name': 'Small Cell Lung Cancer', 'score': 0.9893, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/vandetanib', 'display_name': 'Vandetanib', 'score': 0.66164666}, {'id': 'https://openalex.org/keywords/cabozantinib', 'display_name': 'Cabozantinib', 'score': 0.65019965}, {'id': 'https://openalex.org/keywords/cancer-progression', 'display_name': 'Cancer Progression', 'score': 0.516756}, {'id': 'https://openalex.org/keywords/gene-expression-regulation', 'display_name': 'Gene Expression Regulation', 'score': 0.512598}, {'id': 'https://openalex.org/keywords/gene-rearrangement', 'display_name': 'Gene rearrangement', 'score': 0.507829}, {'id': 'https://openalex.org/keywords/targeted-therapy', 'display_name': 'Targeted therapy', 'score': 0.43859968}], 'concepts': [{'id': 'https://openalex.org/C2775999482', 'wikidata': 'https://www.wikidata.org/wiki/Q18031208', 'display_name': 'ROS1', 'level': 4, 'score': 0.7526853}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.7212695}, {'id': 'https://openalex.org/C2780333294', 'wikidata': 'https://www.wikidata.org/wiki/Q7914515', 'display_name': 'Vandetanib', 'level': 4, 'score': 0.66164666}, {'id': 'https://openalex.org/C2781064419', 'wikidata': 'https://www.wikidata.org/wiki/Q795057', 'display_name': 'Cabozantinib', 'level': 3, 'score': 0.65019965}, {'id': 'https://openalex.org/C111829193', 'wikidata': 'https://www.wikidata.org/wiki/Q1108970', 'display_name': 'Fusion gene', 'level': 3, 'score': 0.610819}, {'id': 'https://openalex.org/C2776256026', 'wikidata': 'https://www.wikidata.org/wiki/Q47912', 'display_name': 'Lung cancer', 'level': 2, 'score': 0.5919778}, {'id': 'https://openalex.org/C42362537', 'wikidata': 'https://www.wikidata.org/wiki/Q87099740', 'display_name': 'Tyrosine kinase', 'level': 3, 'score': 0.5338992}, {'id': 'https://openalex.org/C2992511266', 'wikidata': 'https://www.wikidata.org/wiki/Q1093098', 'display_name': 'Gene rearrangement', 'level': 3, 'score': 0.507829}, {'id': 'https://openalex.org/C101544691', 'wikidata': 'https://www.wikidata.org/wiki/Q420511', 'display_name': 'Receptor tyrosine kinase', 'level': 3, 'score': 0.5053387}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.4905252}, {'id': 'https://openalex.org/C2781230642', 'wikidata': 'https://www.wikidata.org/wiki/Q492646', 'display_name': 'Targeted therapy', 'level': 3, 'score': 0.43859968}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.4154284}, {'id': 'https://openalex.org/C2781182431', 'wikidata': 'https://www.wikidata.org/wiki/Q356033', 'display_name': 'Adenocarcinoma', 'level': 3, 'score': 0.38405883}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3787207}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.36512327}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.3578}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.34075314}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.21012786}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.19475275}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://tcr.amegroups.com/article/view/15559/html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764965054', 'display_name': 'Translational Cancer Research', 'issn_l': '2218-676X', 'issn': ['2218-676X', '2219-6803'], 'is_oa': True, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310321814', 'host_organization_name': 'AME Publishing Company', 'host_organization_lineage': ['https://openalex.org/P4310321814'], 'host_organization_lineage_names': ['AME Publishing Company'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.86, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3151394506', 'https://openalex.org/W3130745906', 'https://openalex.org/W3015316311', 'https://openalex.org/W2961566889', 'https://openalex.org/W2904666257', 'https://openalex.org/W2901045644', 'https://openalex.org/W2890732194', 'https://openalex.org/W2783229347', 'https://openalex.org/W2767967899', 'https://openalex.org/W2767641760', 'https://openalex.org/W2751944337', 'https://openalex.org/W2610943374', 'https://openalex.org/W2576204976', 'https://openalex.org/W2319807719', 'https://openalex.org/W2246525736', 'https://openalex.org/W2133668831', 'https://openalex.org/W2117975608', 'https://openalex.org/W2098805259', 'https://openalex.org/W2090134454', 'https://openalex.org/W2084721357'], 'abstract_inverted_index': {'Non-small': [0], 'cell': [1], 'lung': [2, 222], 'cancer': [3], '(NSCLC)': [4], 'has': [5, 125], 'been': [6, 188], 'recognized': [7], 'as': [8, 21, 103, 190], 'a': [9, 79, 84], 'heterogeneous': [10], 'set': [11], 'of': [12, 63, 70, 112, 194], 'diseases': [13], 'according': [14], 'to': [15, 88, 110, 206], 'oncogenic': [16, 105], 'gene': [17], 'alterations': [18, 106], 'level,': [19], 'such': [20], 'sensitizing': [22, 47], 'EGFR': [24, 49], 'mutations,': [26, 51], 'ALK': [28, 53], 'rearrangements,': [30, 59], 'or': [31, 55, 214], 'ROS1': [33, 57], 'rearrangements': [35, 100, 124, 204], '(1).': [36], 'Specific': [37], 'molecularly': [38], 'targeted': [39], 'therapies': [40], 'are': [41, 235], 'effective': [42], 'in': [43, 108, 129, 134, 145, 157, 198, 209, 219, 247], 'NSCLC': [44, 115, 199, 253], 'patients': [45, 113, 220, 248], 'harboring': [46], 'with': [60, 114, 142, 221, 249], 'response': [61], 'rates': [62], 'approximately': [64], '60%': [65], 'and': [66, 132, 147, 183, 218, 232], 'median': [67], 'progression-free': [68], 'survival': [69], 'over': [71], '10': [72], 'months': [73], '(2-4).': [74], 'RET': [76, 98, 122, 138, 196, 202, 241, 251], 'is': [78, 118, 151], 'proto-oncogene': [80], 'that': [81, 120, 230], 'codes': [82], 'for': [83], 'transmembrane': [85], 'protein': [86], 'belonging': [87], 'the': [89, 152], 'receptor': [90], 'tyrosine': [91, 237], 'kinases': [92], 'family': [93], '(5).': [94], 'In': [95], '2012,': [96], 'were': [101], 'identified': [102, 189], 'new': [104], 'occurring': [107], '1%': [109], '2%': [111], '(6-9).': [116], 'It': [117], 'reported': [119, 229], 'tumor-driving': [126], 'activity': [127, 246], 'vitro': [130], 'vivo': [135], '.': [136], 'can': [140], 'partner': [141, 156], 'different': [143], 'genes': [144, 163], 'NSCLC,': [146], 'KIF5B': [149], 'most': [153], 'common': [154], 'fusion': [155, 192], 'NSCLC.': [158], 'To': [159], 'date,': [160], 'several': [161], 'other': [162, 191], 'including': [164], 'CCDC6,': [166], 'NCOA,': [169], 'TRIM33,': [172], 'CUX1,': [175], 'KIAA1468,': [178], 'KIAA1217,': [181], 'FRMD4A,': [185], 'have': [187, 244], 'partners': [193], 'patients.': [200], 'tend': [205], 'be': [207], 'found': [208], 'younger': [210], 'patients,': [211], 'female,': [212], 'never': [213], 'former': [215], 'light': [216], 'smokers,': [217], 'adenocarcinomas': [223], '(10).': [224], 'A': [225], 'few': [226], 'case': [227], 'reports': [228], 'cabozantinib': [231], 'vandetanib,': [233], 'which': [234], 'multi-targeted': [236], 'kinase': [238, 242], 'inhibitor': [239], 'exhibiting': [240], 'activity,': [243], 'antitumor': [245], '-rearranged': [252], '(11-13).': [254]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2752189410', 'counts_by_year': [], 'updated_date': '2024-09-25T06:57:10.058286', 'created_date': '2017-09-15'}